DYNC1I1 Promotes the Proliferation and Migration of Gastric Cancer by Up-Regulating IL-6 Expression

by Li-Bao Gong, Li-Bao Gong, Ti Wen, Ti Wen, Zhi Li, Zhi Li, Xing Xin, Xing Xin, Xiao-Fang Che, Xiao-Fang Che, Jin Wang, Jin Wang, Yun-Peng Liu, Yun-Peng Liu, Xiu-Juan Qu, Xiu-Juan Qu
Published 2019-06-01

The Role of E3 Ubiquitin Ligase Cbl Proteins in β-Elemene Reversing Multi-Drug Resistance of Human Gastric Adenocarcinoma Cells

by Xue-Jun Hu, Xiu-Juan Qu, Na Song, Ying Luo, En-Zhe Li, Xiao-Dong Mu, Ye Zhang, Yun-Peng Liu
Published 2013-05-01

The Role of E3 Ubiquitin Ligase Cbl Proteins in Interleukin-2-Induced Jurkat T-Cell Activation

by Ming-Fang Zhao, Xiu-Juan Qu, Jing-Lei Qu, You-Hong Jiang, Ye Zhang, Ke-Zuo Hou, Hao Deng, Yun-Peng Liu
Published 2013-01-01

Atezolizumab Monotherapy or Plus Chemotherapy in First-Line Treatment for Advanced Non-Small Cell Lung Cancer Patients: A Meta-Analysis

by Dan-Ni Li, Dan-Ni Li, Dan-Ni Li, Wen-Qing Lu, Wen-Qing Lu, Wen-Qing Lu, Bo-Wen Yang, Bo-Wen Yang, Bo-Wen Yang, Ling-Yun Zhang, Ling-Yun Zhang, Ling-Yun Zhang, Bo Jin, Bo Jin, Bo Jin, Shuo Wang, Shuo Wang, Shuo Wang, Xiao-Fang Che, Xiao-Fang Che, Xiao-Fang Che, Ce Li, Ce Li, Ce Li, Yun-Peng Liu, Yun-Peng Liu, Yun-Peng Liu, Xiu-Juan Qu, Xiu-Juan Qu, Xiu-Juan Qu
Published 2021-06-01

Inhibition of FEN1 Increases Arsenic Trioxide-Induced ROS Accumulation and Cell Death: Novel Therapeutic Potential for Triple Negative Breast Cancer

by Xing Xin, Xing Xin, Ti Wen, Ti Wen, Li-Bao Gong, Li-Bao Gong, Ming-Ming Deng, Ke-Zuo Hou, Ke-Zuo Hou, Lu Xu, Lu Xu, Sha Shi, Sha Shi, Xiu-Juan Qu, Xiu-Juan Qu, Yun-Peng Liu, Yun-Peng Liu, Xiao-Fang Che, Xiao-Fang Che, Yue-E Teng, Yue-E Teng
Published 2020-04-01

Distinction Between Variability-Based Modulation and Mean-Based Activation Revealed by BOLD-fMRI and Eyes-Open/Eyes-Closed Contrast

by Pei-Wen Zhang, Xiu-Juan Qu, Shu-Fang Qian, Xin-Bo Wang, Rui-Di Wang, Qiu-Yue Li, Shi-Yu Liu, Lihong Chen, Dong-Qiang Liu
Published 2018-07-01

Optimal duration of fluorouracil-based adjuvant chemotherapy for patients with resectable gastric cancer.

by Jing-lei Qu, Xin Li, Xiu-Juan Qu, Zhi-tu Zhu, Li-zhong Zhou, Yue-e Teng, Jing-dong Zhang, Bo Jin, Ming-fang Zhao, Ping Yu, Yun-peng Liu
Published 2013-01-01

Prognostic Model Based on Systemic Inflammatory Response and Clinicopathological Factors to Predict Outcome of Patients with Node-Negative Gastric Cancer.

by Jing-lei Qu, Xiu-juan Qu, Zhi Li, Jing-dong Zhang, Jing Liu, Yue-e Teng, Bo Jin, Ming-fang Zhao, Ping Yu, Jing Shi, Ling-Yu Fu, Zhen-ning Wang, Yun-peng Liu
Published 2015-01-01

The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of gastric cancer, 2021

by Feng‐Hua Wang, Xiao‐Tian Zhang, Yuan‐Fang Li, Lei Tang, Xiu‐Juan Qu, Jie‐Er Ying, Jun Zhang, Ling‐Yu Sun, Rong‐Bo Lin, Hong Qiu, Chang Wang, Miao‐Zhen Qiu, Mu‐Yan Cai, Qi Wu, Hao Liu, Wen‐Long Guan, Ai‐Ping Zhou, Yu‐Jing Zhang, Tian‐Shu Liu, Feng Bi, Xiang‐Lin Yuan, Sheng‐Xiang Rao, Yan Xin, Wei‐Qi Sheng, Hui‐Mian Xu, Guo‐Xin Li, Jia‐Fu Ji, Zhi‐Wei Zhou, Han Liang, Yan‐Qiao Zhang, Jing Jin, Lin Shen, Jin Li, Rui‐Hua Xu
Published 2021-08-01